Pharvaris NV (PHVS)
22.29
+1.25
(+5.94%)
USD |
NASDAQ |
Nov 22, 16:00
22.08
-0.20
(-0.92%)
After-Hours: 20:00
Pharvaris Total Liabilities (Quarterly): 18.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.30M |
| June 30, 2024 | 20.45M |
| March 31, 2024 | 19.90M |
| December 31, 2023 | 16.19M |
| September 30, 2023 | 17.16M |
| June 30, 2023 | 17.40M |
| March 31, 2023 | 20.34M |
| December 31, 2022 | 19.81M |
| September 30, 2022 | 17.51M |
| Date | Value |
|---|---|
| June 30, 2022 | 16.89M |
| March 31, 2022 | 11.43M |
| December 31, 2021 | 8.081M |
| September 30, 2021 | 8.890M |
| June 30, 2021 | 8.922M |
| March 31, 2021 | 9.908M |
| December 31, 2020 | 6.536M |
| September 30, 2020 | 5.124M |
| December 31, 2019 | 2.155M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.155M
Minimum
Dec 2019
20.45M
Maximum
Jun 2024
13.61M
Average
16.54M
Median
Total Liabilities (Quarterly) Benchmarks
| uniQure NV | 589.98M |
| ProQR Therapeutics NV | 91.44M |
| Merus NV | 141.42M |
| argenx SE | -- |
| Pharming Group | 199.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 349.79M |
| Shareholders Equity (Quarterly) | 331.48M |